ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109451 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109451; 2) Community: the network communities that were significantly associated with the response to NSC 109451; 3) Molecule: the relationships between components within communities and NSC 109451; 4) MDR: the compounds that were significantly associated with the NSC 109451.

NSC Compound Enrichment Correlation
NSC 287459 Cytarabine AY 0.0386895225700407 -0.1700194
NSC 35580 Null 0.0386895225700407 -0.16277866
NSC 659609 Null 0.0386895225700407 -0.050281145
NSC 676776 Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-D-xylopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylopyranosyl)]- 0.0386895225700407 -0.22460223
NSC 677411 HWA 486 0.0386895225700407 0.056511071
NSC 681638 Camptothecin Derivative 0.0386895225700407 0.17826793
NSC 685503 Propanedinitrile, [5-amino-3,6-dicyano-1,2,4-trihydro-11b-methyl- [1]benzopyrano[2,3,4-de][1,6]naphthyridin-2-ylidene- 0.0386895225700407 -0.080549599
NSC 686428 Null 0.0386895225700407 0.33520946
NSC 688303 Null 0.0386895225700407 0.066580831
NSC 705534 Faradiol 0.0386895225700407 -0.17887338
Total:114  Current:81    [First] [Prev] [Next] [Last]